Table 1 Clinical variables in the randomized groups

Carbohydrate group (N=26)

Fasting group (N=35)

Carbohydrate group with tissue (n=16)

Fasting group with tissue (n=13)

 <55

12 (46%)

16 (46%)

9 (56%)

7 (53%)

 ≥ 55

14 (54%)

19 (54%)

7 (44%)

6 (46%)

 Negative

19 (70%)

25 (71%)

11 (69%)

9 (69%)

 Positive

8 (30%)

10 (29%)

5 (31%)

4 (31%)

 pT1 (<2cm)

16 (61%)

30 (85%)^a

7 (44%)

9 (69%)

 pT2 (≥2cm)

10 (39%)

5 (14%)

9 (57%)

4 (31%)

 1

4 (15%)

7 (20%)

2 (13%)

2 (15%)

 2

10 (37%)

20 (57%)

4 (25%)

7 (53%)

 3

13 (48%)

8 (23%)

10 (63%)

4 (31%)

 Positive

21 (81%)

29 (83%)

11 (69%)

9 (69%)

 Negative

5 (19%)

6 (17%)

5 (31%)

4 (31%)

 Positive

13 (50%)

28 (80%)^b

7 (44%)

11 (85%)

 Negative

13 (50%)

7 (20%)

9 (56%)

2 (15%)

 Negative

23 (88%)

34 (97%)

13 (81%)

12 (92%)

 Positive

3 (12%)

1 ( 3%)

3 (19%)

1 (8%)

 <10

14 (56%)

27 (77%)

6 (38%)

10 (77%)

 ≥ 10

11 (44%)

8 (23%)

10 (62%)

3 (23%)

 <13

14 (56%)

21 (60%)

7 (44%)

6 (46%)

 ≥ 13

12 (44%)

14 (40%)

9 (56%)

7 (54%)

 ≥ 15

17 (65%)

17 (50%)

3 (19%)

5 (42%)

 <15

9 (35%)

17 (50%)

13 (81%)

7 (58%)

 ≥ 30

12 (46%)

10 (29%)

6 (38%)

8 (67%)

 <30

14 (54%)

24 (71%)

10 (62%)

4 (33%)

 <10%

24 (92%)

31 (89%)

15 (94%)

13 (100%)

 ≥10%

2 (8%)

4 (11%)

1 (6%)

0 (0%)

 No distant metastasis

22 (85%)

33 (94%)

11 (67%)

11 (85%)

 Distant metastasis

4 (15%)

2 (6%)

3 (20%)

1 (7%)